UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET FORECAST 2022-2028


TABLE OF CONTENTS

1.     RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES

1.2. SCOPE OF STUDY

1.3. METHODOLOGY

1.4. ASSUMPTIONS & LIMITATIONS

2.     EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES

2.2. COUNTRY SNAPSHOT

2.3. COUNTRY ANALYSIS

2.4. KEY GROWTH ENABLERS

2.5. KEY CHALLENGES

3.     KEY ANALYTICS

3.1. PARENT MARKET ANALYSIS

3.2. TIMELINE OF ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET

3.3. PHASES AND STERNNESS OF ALZHEIMER’S DISEASE

3.4. IMPACT OF COVID-19 ON ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET

3.5. KEY MARKET TRENDS

3.6. PORTER’S FIVE FORCES ANALYSIS

3.6.1.   BUYERS POWER

3.6.2.   SUPPLIERS POWER

3.6.3.   SUBSTITUTION

3.6.4.   NEW ENTRANTS

3.6.5.   INDUSTRY RIVALRY

3.7. KEY BUYING CRITERIA

3.8. SUPPLY CHAIN ANALYSIS

3.9. OPPORTUNITY MATRIX

3.10.               PESTLE ANALYSIS - UNITED STATES

4.     MARKET BY THERAPEUTICS & DIAGNOSTICS

4.1. THERAPEUTICS

4.1.1.   DRUGS

4.1.1.1.        MARKETED DRUGS

4.1.1.2.        PIPELINE DRUGS

4.1.2.   DISEASE STAGE

4.1.2.1.        LATE-STAGE: SEVERE AD

4.1.2.2.        EARLY/MIDDLE STAGE: MILD TO MODERATE AD

4.1.2.3.        PRODROMAL STAGE

4.1.3.   GENERIC & BRANDED

4.1.3.1.        BRANDED

4.1.3.2.        GENERIC

4.2. DIAGNOSTICS

4.2.1.   LUMBAR PUNCTURE TEST

4.2.2.   POSITRON EMISSION TOMOGRAPHY

4.2.3.   ELECTROENCEPHALOGRAPHY

4.2.4.   MAGNETIC RESONANCE IMAGING

4.2.5.   COMPUTED TOMOGRAPHY

4.2.6.   BLOOD TEST

4.2.7.   OTHER DIAGNOSTICS

5.     COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIC DEVELOPMENTS

5.1.1.   MERGERS & ACQUISITIONS

5.1.2.   PRODUCT LAUNCHES & DEVELOPMENTS

5.1.3.   PARTNERSHIPS & AGREEMENTS

5.1.4.   BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

5.2. COMPANY PROFILES

5.2.1.   AMARANTUS BIOSCIENCE HOLDINGS INC

5.2.2.   BAXTER INTERNATIONAL INC

5.2.3.   BIOGEN INC

5.2.4.   COGNOPTIX INC

5.2.5.   ELI LILLY & COMPANY

5.2.6.   GE HEALTHCARE

5.2.7.   JOHNSON & JOHNSON

5.2.8.   MERCK & CO INC

5.2.9.   PFIZER INC

 

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS

TABLE 2: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 3: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, FORECAST YEARS, 2022-2028 (IN $ MILLION)

TABLE 4: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2022-2028 (IN $ MILLION)

TABLE 6: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

TABLE 8: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, FORECAST YEARS, 2022-2028 (IN $ MILLION)

TABLE 10: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, FORECAST YEARS, 2022-2028 (IN $ MILLION)

TABLE 12: LIST OF MERGERS & ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 15: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

 

LIST OF FIGURES

FIGURE 1: PIPELINE DRUGS RELATED TO ALZHEIMER’S DISEASE

FIGURE 2: KEY MARKET TRENDS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: KEY BUYING CRITERIA

FIGURE 5: SUPPLY CHAIN ANALYSIS

FIGURE 6: OPPORTUNITY MATRIX

FIGURE 7: PESTLE ANALYSIS - UNITED STATES

FIGURE 8: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY THERAPEUTICS & DIAGNOSTICS, IN 2021

FIGURE 9: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS, 2022-2028 (IN $ MILLION)

FIGURE 10: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUGS, IN 2021

FIGURE 11: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY MARKETED DRUGS, 2022-2028 (IN $ MILLION)

FIGURE 12: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY PIPELINE DRUGS, 2022-2028 (IN $ MILLION)

FIGURE 13: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DISEASE STAGE, IN 2021

FIGURE 14: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY LATE-STAGE: SEVERE AD, 2022-2028 (IN $ MILLION)

FIGURE 15: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY EARLY/MIDDLE STAGE: MILD TO MODERATE AD, 2022-2028 (IN $ MILLION)

FIGURE 16: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY PRODROMAL STAGE, 2022-2028 (IN $ MILLION)

FIGURE 17: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY GENERIC & BRANDED, IN 2021

FIGURE 18: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY BRANDED, 2022-2028 (IN $ MILLION)

FIGURE 19: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS MARKET, BY GENERIC, 2022-2028 (IN $ MILLION)

FIGURE 20: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)

FIGURE 21: UNITED STATES ALZHEIMER’S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY DIAGNOSTICS, IN 2021

FIGURE 22: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY LUMBAR PUNCTURE TEST, 2022-2028 (IN $ MILLION)

FIGURE 23: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY POSITRON EMISSION TOMOGRAPHY, 2022-2028 (IN $ MILLION)

FIGURE 24: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY ELECTROENCEPHALOGRAPHY, 2022-2028 (IN $ MILLION)

FIGURE 25: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY MAGNETIC RESONANCE IMAGING, 2022-2028 (IN $ MILLION)

FIGURE 26: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY COMPUTED TOMOGRAPHY, 2022-2028 (IN $ MILLION)

FIGURE 27: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY BLOOD TEST, 2022-2028 (IN $ MILLION)

FIGURE 28: UNITED STATES ALZHEIMER’S DISEASE DIAGNOSTICS MARKET, BY OTHER DIAGNOSTICS, 2022-2028 (IN $ MILLION)

 

KEY FINDINGS

The United States Alzheimer’s disease therapeutics & diagnostics market is estimated to progress with a 6.62% CAGR during the forecasting years 2022-2028. The market growth is driven by regular cognitive assessments of senior citizens and the easy availability of relevant drugs.

 

Get more Insights into the United States Alzheimer’s Disease Therapeutics & Diagnostics Market:

https://inkwoodresearch.com/reports/united-states-alzheimers-disease-therapeutics-and-diagnostics-market/

 

MARKET INSIGHTS

Alzheimer’s is a degenerative disorder that attacks the neurons, affecting thinking, memory loss, behavioral changes, and language skills. The market is anticipated to grow, driven by the vast number of last-stage pipeline and disease-modifying drugs. The United States is the largest player in Alzheimer’s disease diagnostics and therapeutics market. Besides, the country also has high expenditure on disease management and high detection rates in primary care settings. According to the US Census Bureau, the population of Americans aged 65+ is expected to surge to 88 million by 2050. These factors are expected to drive the market growth during the forecast years.

Furthermore, the United States Food and Drug Administration has approved various molecules to treat Alzheimer’s disease. Also, a combination drug containing Memantine and Donepezil is widely available in the market. The availability of various drugs and molecules to cure the disease produces lucrative opportunities for medicine manufacturers.

 

COMPETITIVE INSIGHTS

Leading players in the market include GE Healthcare, Baxter International Inc, Amarantus Bioscience Holdings Inc, Cognoptix Inc, Merck & Co Inc, etc.

 

Our report offerings include:

·       Explore key findings of the overall market

·       Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

·       Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

·       Market Segmentation caters to a thorough assessment of key segments with their market estimations

·       Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

·       Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

·       Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

·       Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

 

SEGMENTATION

1.    AMARANTUS BIOSCIENCE HOLDINGS INC

2.    BAXTER INTERNATIONAL INC

3.    BIOGEN INC

4.    COGNOPTIX INC

5.    ELI LILLY & COMPANY

6.    GE HEALTHCARE

7.    JOHNSON & JOHNSON

8.    MERCK & CO INC

9.    PFIZER INC

 

Comments

Post a Comment

Popular posts from this blog

High Voltage Cable Market: Major End-Users Augment Demands

Image
  High voltage cables (HVCs) are the backbone of electrical infrastructure globally. From their use in commercial and residential infrastructures to industrial end uses in mining, oil & gas factories, power & utilities, etc., HVCs are crucial supplements to the growth of the power sector. Besides, urbanization and industrialization globally are increasing the demand for electric power. Therefore, the surging power demand is expected to result in more power generation and transmission, thereby propelling the requirement for high voltage cables. Inkwood Research predicts that the global high voltage cable market is set to surge with a 5.12% CAGR during the forecast period 2023-2032 .   High Voltage Cable Market: Major End Uses HVCs are extensively utilized for high voltage electric power transmission. Equipped with multiple conductors, structural elements of protective jackets, and insulators, they are designed to transmit electricity efficiently without long-ra...
Read more

UAV Battery Market: Military & Commercial Applications direct Growth

Image
  Unmanned aerial vehicles (UAVs) or automated drones fly for long periods at a controlled speed and height and have a role in many aspects of aviation. They are used in various functions, ranging from food delivery, filming, photography, climate change monitoring, and search operations after natural disasters. With the growing geo-political tension among major countries, UAVs have gained massive demand. This is because drones are used by the military worldwide for surveillance, reconnaissance, and targeted attacks. These devices operate wirelessly, creating a huge requirement for UAV batteries for optimal use. Accordingly, as per our research, the   global UAV battery market   is estimated to generate a whopping   $17.7 billion   in revenue, with a   16.32% CAGR   during the forecast years,   2022-2030 .   UAV Battery: Growing Military Applications Militaries need UAVs for training in combat situations and ISR (intelligence, surveillance, an...
Read more

X-Ray Tube Market: Trending Applications & Novel Developments

Image
 X-ray tube, also known as a Roentgen tube, functions as a specific energy converter that receives electrical energy and converts it into heat (99%) and x-radiation (1%). The primary function of an X-ray tube is to create x-ray photons from electric energy transmitted by the x-ray generator. As per Inkwood Research, the global X-ray tube market is forecasted to rise with a CAGR of 3.81% during the projected years of 2022 to 2030 . Their widespread usage across applications, such as material and structure analysis, CT scanners, X-ray crystallography, and airport luggage scanners, among others, play an essential role in surging the demand and adoption of X-ray tubes worldwide.   X-Ray – An Incredible Contribution to Human Health The discovery of the X-ray in 1895 provided physicians with an effective, non-surgical tool to analyze the inside of the human body. Moreover, following the development of the ‘Coolidge tube’ in 1913, which continues to remain the model that...
Read more